Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 6 studies | 28% ± 6% | |
endothelial cell | 5 studies | 23% ± 8% | |
GABAergic neuron | 5 studies | 37% ± 17% | |
epithelial cell | 4 studies | 25% ± 5% | |
glutamatergic neuron | 4 studies | 52% ± 18% | |
astrocyte | 4 studies | 23% ± 9% | |
microglial cell | 3 studies | 17% ± 0% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 5% | |
interneuron | 3 studies | 43% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 37% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3367.85 | 459 / 459 | 100% | 23.18 | 1118 / 1118 |
esophagus | 100% | 2871.57 | 1445 / 1445 | 100% | 19.46 | 183 / 183 |
prostate | 100% | 3830.64 | 245 / 245 | 100% | 23.52 | 502 / 502 |
uterus | 100% | 3940.96 | 170 / 170 | 100% | 22.06 | 459 / 459 |
lung | 100% | 2803.34 | 577 / 578 | 100% | 16.86 | 1155 / 1155 |
bladder | 100% | 2932.10 | 21 / 21 | 100% | 16.99 | 503 / 504 |
ovary | 100% | 3955.68 | 180 / 180 | 100% | 12.72 | 429 / 430 |
thymus | 100% | 3579.57 | 653 / 653 | 100% | 18.02 | 603 / 605 |
pancreas | 100% | 2437.48 | 328 / 328 | 99% | 17.26 | 177 / 178 |
adrenal gland | 100% | 3079.77 | 258 / 258 | 99% | 13.94 | 228 / 230 |
brain | 99% | 2685.30 | 2615 / 2642 | 100% | 19.08 | 705 / 705 |
stomach | 100% | 2457.33 | 359 / 359 | 98% | 13.27 | 281 / 286 |
kidney | 100% | 2341.94 | 89 / 89 | 98% | 13.76 | 885 / 901 |
intestine | 100% | 3401.41 | 966 / 966 | 98% | 14.01 | 517 / 527 |
skin | 100% | 3661.27 | 1809 / 1809 | 94% | 15.28 | 442 / 472 |
liver | 99% | 1337.89 | 224 / 226 | 91% | 8.27 | 371 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.00 | 29 / 29 |
spleen | 100% | 3438.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.79 | 1 / 1 |
adipose | 100% | 2918.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2430.89 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1680.45 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1334.44 | 842 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 8.52 | 53 / 80 |
peripheral blood | 40% | 1102.76 | 375 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000395 | Biological process | mRNA 5'-splice site recognition |
GO_0000243 | Cellular component | commitment complex |
GO_0071004 | Cellular component | U2-type prespliceosome |
GO_0005685 | Cellular component | U1 snRNP |
GO_0005515 | Molecular function | protein binding |
GO_0030627 | Molecular function | pre-mRNA 5'-splice site binding |
Gene name | PRPF39 |
Protein name | PRPF39 protein Pre-mRNA processing factor 39 Pre-mRNA-processing factor 39 (PRP39 homolog) |
Synonyms | |
Description | FUNCTION: Involved in pre-mRNA splicing. . |
Accessions | ENST00000554439.5 ENST00000553605.1 ENST00000554429.5 ENST00000554081.5 Q05CV8 F8WB90 G3V5M7 H0YJY9 ENST00000557477.1 ENST00000424478.5 Q86UA1 ENST00000355765.11 [Q86UA1-1] H0YJR1 |